|
Volumn 11, Issue 5, 2001, Pages 341-346
|
Brief communication: Delivery of a hammerhead ribozyme specifically downregulates mutant type I collagen mRNA in a murine model of osteogenesis imperfecta
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COLLAGEN TYPE 1;
HAMMERHEAD RIBOZYME;
MESSENGER RNA;
RIBOZYME;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CALVARIA;
CLINICAL FEATURE;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
DRUG DELIVERY SYSTEM;
GENE CONTROL;
GENE EXPRESSION;
GENE MUTATION;
GENE TARGETING;
MOUSE;
NONHUMAN;
OSTEOBLAST;
OSTEOGENESIS IMPERFECTA;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
ANIMAL;
CELL STRAIN 3T3;
CHEMISTRY;
DISEASE MODEL;
DOWN REGULATION;
DRUG EFFECT;
GENETIC TRANSCRIPTION;
GENETICS;
NUCLEOTIDE SEQUENCE;
ANIMALIA;
MURINAE;
3T3 CELLS;
ANIMAL;
BASE SEQUENCE;
COLLAGEN TYPE I;
DISEASE MODELS, ANIMAL;
DOWN-REGULATION;
MICE;
OSTEOGENESIS IMPERFECTA;
RNA, CATALYTIC;
RNA, MESSENGER;
SUPPORT, NON-U.S. GOV'T;
TRANSCRIPTION, GENETIC;
|
EID: 0035181561
PISSN: 10872906
EISSN: None
Source Type: Journal
DOI: 10.1089/108729001753231722 Document Type: Article |
Times cited : (14)
|
References (19)
|